The FTO-ALKBH5/IGF2BP2-m6A axis mediates the stabilization of HK2 mRNA, leading to the downregulation of HK2 expression, which restrains the FOXO signaling pathway to suppress CRC progression (27). The gene discussed is FTO; the disease is colorectal carcinoma.